Wednesday, February 27, 2013

• U.S. Food and Drug Administration Approved 30% More Drugs in 2012 than the Year PreviousMarketwired (Wed, Feb 27)

Thursday, February 21, 2013

• Speculative Biotech Stocks That Could Bounce 50% On Upcoming Catalystsat Seeking Alpha (Thu, Feb 21)

Wednesday, February 20, 2013

• ZALICUS INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Wed, Feb 20)
• Zalicus Granted Composition-of-Matter Patent for Z944Business Wire (Wed, Feb 20)

Tuesday, February 12, 2013

• ZALICUS INC. Files SEC form 8-K, Regulation FD DisclosureEDGAR Online (Tue, Feb 12)

Tuesday, February 5, 2013

• Zalicus to Present at the 2013 BIO CEO & Investor ConferenceBusiness Wire (Tue, Feb 5)

Thursday, January 31, 2013

• 5 Stocks Under $10 Set to Soar Higherat TheStreet (Thu, Jan 31)

Tuesday, January 22, 2013

• Meeting With Zalicus Management Confirms Z160 Potential; Big Pharma Awaiting Trial Dataat Seeking Alpha (Tue, Jan 22)

Friday, January 18, 2013

• Zalicus stock drops after CEO sells 113,000 sharesat bizjournals.com (Fri, Jan 18)

Tuesday, January 15, 2013

• The Future Of Zalicus In 2013at Seeking Alpha (Tue, Jan 15)
• Biotech Industry Expected to Experience More M&A Activity in 2013Marketwired (Tue, Jan 15)

Thursday, January 10, 2013

• Will 2013 Be A Better Year For Zalicus?at Seeking Alpha (Thu, Jan 10)

Wednesday, January 9, 2013

• ZALICUS INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and ExhibitsEDGAR Online (Wed, Jan 9)

Thursday, January 3, 2013

• 2 Biotech Companies Making Considerable Strides When It Comes To Pain Managementat Seeking Alpha (Thu, Jan 3)
• ZALICUS INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Thu, Jan 3)
• Zalicus Initiates the Second of Two Phase 2a Studies with Z160Business Wire (Thu, Jan 3)

Wednesday, December 5, 2012

• Zalicus to Present at the Oppenheimer 23rd Annual Healthcare ConferenceBusiness Wire (Wed, Dec 5)
• Top 5 Fiscal Cliff Biotech Buysat Seeking Alpha (Wed, Dec 5)

Tuesday, December 4, 2012

• 3 Small-Cap Biopharmas With Trade Catalysts And Speculation Investment Potentialat Seeking Alpha (Tue, Dec 4)

Wednesday, November 28, 2012

• Teva: What Would Be The Best Acquisition Candidate?at Seeking Alpha (Wed, Nov 28)
• Smart Day Traders Ring The Register On Acadia And Zalicusat Seeking Alpha (Wed, Nov 28)

Tuesday, November 27, 2012

• ZALICUS INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Tue, Nov 27)
• Zalicus’ Z160 for Chronic Neuropathic Pain Selected as a Top 10 Project to WatchBusiness Wire (Tue, Nov 27)

Monday, November 26, 2012

• Zalicus: Bears And Bullsat Seeking Alpha (Mon, Nov 26)

Tuesday, November 20, 2012

• Pfizer: Does it Need a Future Substitute for Lyrica?at Motley Fool (Tue, Nov 20)

Add ZLCS News to My Yahoo!